Impact of ABO blood groups on residual pulmonary vascular obstruction in patients with unprovoked pulmonary embolism
Floriane Samaria(Université de Bordeaux), David-Alexandre Trégouët(Université de Bordeaux), Robert Olaso(University of Bonn), Marine Germain(Inserm), Grégoire Le Gal(University of Ottawa), Ohanna C. L. Bezerra(University of Toronto), France Gagnon(University of Toronto), Gaëlle Munsch(Université de Bordeaux), Delphine Bacq(Inserm), Marc Rodger(McGill University), Jean-François Deleuze(Inserm), Lénaïck Gourhant(Inserm), Francis Couturaud(Inserm), Catherine A. Lemarié(Inserm)
Cited by 0
Related Papers
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
|Nature Genetics|2017|1.1k
Genetics and Beyond – The Transcriptome of Human Monocytes and Disease Susceptibility
|PLoS ONE|2010|600
Meta-analysis of 65,734 Individuals Identifies TSPAN15 and SLC44A2 as Two Susceptibility Loci for Venous Thromboembolism
|The American Journal of Human Genetics|2015|274
Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism
|Blood|2019|238
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis
|The Lancet Respiratory Medicine|2018|212